Lauterbach Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Buy
47,299
+531
+1% +$13.9K 0.49% 29
2026
Q1
$1.31M Buy
46,768
+519
+1% +$13.8K 0.64% 23
2025
Q4
$1.15M Buy
46,249
+525
+1% +$13.2K 0.56% 27
2025
Q3
$1.17M Buy
45,724
+535
+1% +$13.2K 0.59% 25
2025
Q2
$1.1M Buy
45,189
+527
+1% +$12.3K 0.6% 24
2025
Q1
$1.13M Sell
44,662
-3,285
-7% -$86K 0.71% 22
2024
Q4
$1.27M Buy
47,947
+13,881
+41% +$377K 0.77% 21
2024
Q3
$986K Buy
34,066
+286
+0.8% +$8.34K 0.6% 24
2024
Q2
$1.03M Buy
33,780
+1,485
+5% +$40.9K 0.68% 23
2024
Q1
$896K Buy
32,295
+16,582
+106% +$460K 0.59% 23
2023
Q4
$452K Buy
15,713
+437
+3% +$13.2K 0.32% 36
2023
Q3
$507K Hold
15,276
0.4% 30
2023
Q2
$560K Hold
15,276
0.43% 29
2023
Q1
$623K Sell
15,276
-473
-3% -$20.4K 0.5% 26
2022
Q4
$807K Hold
15,749
0.72% 19
2022
Q3
$689K Hold
15,749
0.7% 20
2022
Q2
$826K Hold
15,749
0.78% 16
2022
Q1
$815K Sell
15,749
-1,000
-6% -$51.9K 0.74% 17
2021
Q4
$989K Buy
+16,749
New +$830K 0.87% 14

Other funds holding PFE

Lauterbach Financial Advisors's PFE Position: Q2 2026 in Review

Lauterbach Financial Advisors increased its Pfizer (PFE) stake by 1.1% in Q2 2026, buying an estimated $13.9K and bringing the position to 47,299 shares worth $1.14M. The position accounts for 0.49% of the portfolio, ranked #29.

Lauterbach Financial Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.31M in Q1 2026. 1,328 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Lauterbach Financial Advisors held 47,299 shares of Pfizer worth $1.14M as of Q2 2026.
  • Lauterbach Financial Advisors bought 531 Pfizer shares in Q2 2026, an estimated $13.9K.
  • Pfizer made up 0.49% of Lauterbach Financial Advisors's portfolio in Q2 2026, its #29 holding.
  • Lauterbach Financial Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Lauterbach Financial Advisors's Pfizer position peaked at $1.31M in Q1 2026.
  • 1,328 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Lauterbach Financial Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.